249 related articles for article (PubMed ID: 33227705)
1. Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment.
Yi X; Liu Y; Zhou B; Xiang W; Deng A; Fu Y; Zhao Y; Ouyang Q; Liu Y; Sun Z; Zhang K; Li X; Zeng F; Zhou H; Chen BT
Biomed Pharmacother; 2021 Jan; 133():111013. PubMed ID: 33227705
[TBL] [Abstract][Full Text] [Related]
2. Rs3802278 in 3'-UTR of
Zeng F; Liu Y; Ouyang Q; Sun Z; Zhang K; Li X; Liu Y
J Chemother; 2021 Dec; 33(8):564-569. PubMed ID: 34029511
[TBL] [Abstract][Full Text] [Related]
3. [Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by multi-sequence MRI-based radiomic nomogram].
Mao MM; Li HM; Shi J; Qiu QS; Feng F
Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):201-208. PubMed ID: 35042289
[No Abstract] [Full Text] [Related]
4. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
Dressman HK; Berchuck A; Chan G; Zhai J; Bild A; Sayer R; Cragun J; Clarke J; Whitaker RS; Li L; Gray J; Marks J; Ginsburg GS; Potti A; West M; Nevins JR; Lancaster JM
J Clin Oncol; 2007 Feb; 25(5):517-25. PubMed ID: 17290060
[TBL] [Abstract][Full Text] [Related]
5. Predicting Ovarian Cancer Patients' Clinical Response to Platinum-Based Chemotherapy by Their Tumor Proteomic Signatures.
Yu KH; Levine DA; Zhang H; Chan DW; Zhang Z; Snyder M
J Proteome Res; 2016 Aug; 15(8):2455-65. PubMed ID: 27312948
[TBL] [Abstract][Full Text] [Related]
6. T2-weighted imaging-based radiomic-clinical machine learning model for predicting the differentiation of colorectal adenocarcinoma.
Zheng HD; Huang QY; Huang QM; Ke XT; Ye K; Lin S; Xu JH
World J Gastrointest Oncol; 2024 Mar; 16(3):819-832. PubMed ID: 38577440
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an
Wang H; Zhao S; Li L; Tian R
Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the radiomics-machine-learning model based on non-contrast enhanced CT for the simplified risk categorization of thymic epithelial tumors: A large cohort retrospective study.
Feng XL; Wang SZ; Chen HH; Huang YX; Xin YK; Zhang T; Cheng DL; Mao L; Li XL; Liu CX; Hu YC; Wang W; Cui GB; Nan HY
Lung Cancer; 2022 Apr; 166():150-160. PubMed ID: 35287067
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
[TBL] [Abstract][Full Text] [Related]
10. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
11. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
13. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
14. Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade.
Shu J; Wen D; Xi Y; Xia Y; Cai Z; Xu W; Meng X; Liu B; Yin H
Eur J Radiol; 2019 Dec; 121():108738. PubMed ID: 31756634
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Lymph Node Metastasis in Advanced Gastric Cancer Using Magnetic Resonance Imaging-Based Radiomics.
Chen W; Wang S; Dong D; Gao X; Zhou K; Li J; Lv B; Li H; Wu X; Fang M; Tian J; Xu M
Front Oncol; 2019; 9():1265. PubMed ID: 31824847
[No Abstract] [Full Text] [Related]
16. Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
Ferriss JS; Kim Y; Duska L; Birrer M; Levine DA; Moskaluk C; Theodorescu D; Lee JK
PLoS One; 2012; 7(2):e30550. PubMed ID: 22348014
[TBL] [Abstract][Full Text] [Related]
17. Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma.
Xu F; Zhu W; Shen Y; Wang J; Xu R; Qutesh C; Song L; Gan Y; Pu C; Hu H
Front Oncol; 2020; 10():872. PubMed ID: 32850301
[No Abstract] [Full Text] [Related]
18. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
[TBL] [Abstract][Full Text] [Related]
19. A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.
Lin P; Yang PF; Chen S; Shao YY; Xu L; Wu Y; Teng W; Zhou XZ; Li BH; Luo C; Xu LM; Huang M; Niu TY; Ye ZM
Cancer Imaging; 2020 Jan; 20(1):7. PubMed ID: 31937372
[TBL] [Abstract][Full Text] [Related]
20. Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study.
Zhao J; Sun Z; Yu Y; Yuan Z; Lin Y; Tan Y; Duan X; Yao H; Wang Y; Liu J
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
